GR does not operate in the US, rather it sells its products under distribution arrangements. Given what I heard and the tone it was delivered at I reckon GR is looking to improve its partner relationships and thus improve its business in the US utilising the existing arrangements. Whether it tweaks the fianacial side of the arrangement who knows. But I reckon GR knows it has an opportunity to work with Mayne Pharma for a mutually more beneficial outcome.
Ann: Class action settlement, page-96
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.61 |
Change
-0.040(0.86%) |
Mkt cap ! $392.1M | |||
| Open | High | Low | Value | Volume |
| $4.66 | $4.70 | $4.57 | $498.0K | 107.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4333 | $4.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.64 | 126 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |